Scott Thomas Smith
Vermogen: 978 688 $ op 31-05-2026
Vermogen: 978 688 $ op 31-05-2026
Momenteel bekleedt Scott Thomas Smith de functie van Chief Financial Officer & Senior Vice President van Ascendis Pharma A. Voordien bekleedde hij de functie van Director-Healthcare Investment Banking Group bij Wedbush Securities, Inc. en Director-Global Healthcare Investment Banking bij Merrill Lynch, Pierce, Fenner & Smith, Inc. De heer Smith behaalde een bachelordiploma aan Claremont McKenna College en een MBA aan de Stanford Graduate School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 02-06-2026 | 4.367 ( -.--% ) | 978 688 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCENDIS PHARMA A/S | Financieel Directeur/CFO | 08-08-2016 |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Financieel Directeur/CFO | 01-08-2016 |
| Bedrijven | Functie | Einde |
|---|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Corporate Officer/Principal | 01-01-2016 |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Claremont McKenna College
Claremont McKenna College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Stanford Graduate School of Business
Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma, Inc.
Ascendis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops endocrinology, rare disease and oncology medicines & transient conjugation platform | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau